ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 85 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.80 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $12,120,000 | +46.6% | 226,757 | +207.8% | 0.02% | +50.0% |
| Q4 2015 | $8,265,000 | +23.1% | 73,677 | +29.2% | 0.01% | +7.7% |
| Q3 2015 | $6,714,000 | -28.8% | 57,045 | -53.2% | 0.01% | -13.3% |
| Q2 2015 | $9,428,000 | +155.1% | 121,776 | +90.6% | 0.02% | +114.3% |
| Q1 2015 | $3,696,000 | +257.8% | 63,904 | +99.4% | 0.01% | +250.0% |
| Q4 2014 | $1,033,000 | +4.3% | 32,055 | -20.7% | 0.00% | 0.0% |
| Q3 2014 | $990,000 | +46.9% | 40,438 | 0.0% | 0.00% | +100.0% |
| Q2 2014 | $674,000 | -56.5% | 40,438 | -57.4% | 0.00% | -66.7% |
| Q1 2014 | $1,549,000 | -25.8% | 95,027 | -12.5% | 0.00% | -25.0% |
| Q4 2013 | $2,089,000 | +27.8% | 108,652 | -29.4% | 0.00% | +33.3% |
| Q3 2013 | $1,634,000 | +163300.0% | 153,884 | +146456.2% | 0.00% | – |
| Q2 2013 | $1,000 | – | 105 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 1,067,892 | $125,702,000 | 41.75% |
| VHCP Management, LLC | 1,178,474 | $138,718,000 | 35.56% |
| Palo Alto Investors LP | 2,579,154 | $303,592,000 | 14.60% |
| Baker Brothers Advisors | 4,135,412 | $486,779,000 | 4.50% |
| APIS CAPITAL ADVISORS, LLC | 23,000 | $2,708,000 | 3.75% |
| EMORY UNIVERSITY | 11,096 | $1,306,000 | 3.64% |
| Atika Capital Management LLC | 61,000 | $7,180,000 | 3.52% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 488,912 | $57,550,000 | 2.78% |
| Segantii Capital Management Ltd | 100,000 | $11,134,000 | 2.55% |
| NEXT CENTURY GROWTH INVESTORS LLC | 428,835 | $50,478,000 | 2.10% |